Target intelligence / Profile preview

SOX2 overlapping transcript, exon 4 (SOX2OT_exon4)

Target
SOX2OT_exon4
Molecular classification
Other, lncRNA, Long non-coding RNA
01

Overview

SOX2 overlapping transcript, exon 4 (SOX2OT_exon4) is a segment of a long non-coding RNA overlapping the SOX2 protein-coding locus. This transcript is not a classical receptor, enzyme, transporter, or gene product targeted by drugs; rather, it is part of a non-coding region thought to be involved in gene regulation at the RNA level, possibly influencing the expression of developmental regulators such as SOX2[1][5]. There is no established role as a therapeutic drug target, no recognized involvement in major disease pathways for this specific exon, and no known direct modulators or biomarkers. This ID is likely not appropriate for drug-target mapping.\n\nKey limitations: ENSG00000278026 is strictly a non-coding RNA transcript, not a protein, receptor, or pharmacological target[1][5]. No canonical drugs, safety concerns, or established mechanism-of-action exist. May be incorrectly included in therapeutic target mapping. If you need structured information for pharmacological targets, the SOX2 gene (SRY-box transcription factor 2, ENSG00000181449) is a protein-coding gene and actual drug/disorder target, distinct from SOX2OT_exon4[7][9].

Other names
SOX2OT_exon4SOX2OT
02

Biological functions

May be involved in epigenetic regulation and transcriptional regulation in neural development, though its exact biological functions remain unclear and are typically context-specific to lncRNAs
03

Disease associations

No direct disease roles established for this exon specifically. Some literature implicates SOX2OT, as a broader lncRNA locus, in nervous system development, stem cell function, and possibly cancer, but not this exact transcript.

Beyond the preview

Go deeper on SOX2 overlapping transcript, exon 4 (SOX2OT_exon4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SOX2 overlapping transcript, exon 4 (SOX2OT_exon4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call